Department of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA.
Department of Pathology, Mayo Clinic, Jacksonville, Florida, USA.
Gastrointest Endosc. 2016 Dec;84(6):1034-1039. doi: 10.1016/j.gie.2016.03.1405. Epub 2016 Mar 24.
EUS-guided fine needle biopsy (FNB) sampling and FNA are important methods for obtaining core tissues and cytologic aspirates. To improve the specimen quality for pathologic evaluation, a novel EUS-FNB Shark Core (SC) needle has been designed to acquire core tissue during EUS procedures. We compared the histology yield of EUS-FNB sampling using the SC needle (EUS-FNB-SC) to EUS-FNA in patients who had solid pancreatic and nonpancreatic lesions.
This was a retrospective case-control study design. Between July 2012 and July 2015 all patients who had EUS-FNB-SC and EUS-FNA were reviewed through a hospital EUS database. Consecutive samples from EUS-FNB-SCs were matched in a 1:3 ratio by lesion site (eg, pancreatic head) and needle gauge (ie, 19 gauge, 22 gauge, 25 gauge) to recent random samples of EUS-FNA. The procedures were performed with rapid onsite evaluation. For study purposes specimen slides were evaluated by 2 cytopathologists for histologic yield using a standard scoring system (0 = no material, 1-2 = cytologic, 3-5 = histologic). The main objectives were to assess the histologic yield of the samples and compare the median number of passes required to obtain core tissue by using EUS-FNB-SC and EUS-FNA needles.
Of the 156 patients included in study, 25% patients (n = 39) were in the EUS-FNB-SC group and 75% (n = 117) in the EUS-FNA group. According to standard scoring criteria for histology, the median histology score for EUS-FNA was 2 (sufficient for cytology but not histology) and for EUS-FNB-SC was 4 (sufficient for adequate histology). Ninety-five percent of the specimens obtained from the EUS-FNB-SC group were of sufficient size for histologic screening, compared with 59% from the EUS-FNA group (P = .01). The median number of passes required to achieve a sample was significantly lower in the EUS-FNB-SC group compared with the EUS-FNA group (2 passes vs 4 passes, P = .001). There was significant difference in the median number of passes to all lesion sites and needle gauges.
The histology yield was significantly higher using the EUS-FNB-SC needle compared with the EUS-FNA needle. Additionally, fewer passes were required to obtain histology cores when using EUS-FNB-SC.
EUS 引导下的细针活检(FNB)采样和 FNA 是获取核心组织和细胞学抽吸物的重要方法。为了提高病理评估的标本质量,设计了一种新型的 EUS-FNB Shark Core(SC)针,以便在 EUS 操作过程中获取核心组织。我们比较了 EUS-FNB-SC 和 EUS-FNA 在有实体胰腺和非胰腺病变患者中的组织学采集效果。
这是一项回顾性病例对照研究设计。2012 年 7 月至 2015 年 7 月,通过医院 EUS 数据库对所有接受 EUS-FNB-SC 和 EUS-FNA 的患者进行了回顾性分析。通过病变部位(如胰头部)和针规(19 号、22 号、25 号)将 EUS-FNB-SC 的连续样本与最近的 EUS-FNA 随机样本以 1:3 的比例匹配。该操作进行了快速现场评估。为了研究目的,通过两位细胞病理学家使用标准评分系统(0=无材料,1-2=细胞学,3-5=组织学)评估标本切片的组织学采集效果。主要目标是评估样本的组织学采集效果,并比较使用 EUS-FNB-SC 和 EUS-FNA 针获取核心组织所需的中位数穿刺次数。
在纳入研究的 156 例患者中,25%(n=39)的患者为 EUS-FNB-SC 组,75%(n=117)为 EUS-FNA 组。根据组织学的标准评分标准,EUS-FNA 的中位数组织学评分为 2 分(足够用于细胞学但不足以用于组织学),而 EUS-FNB-SC 的中位数组织学评分为 4 分(足以用于充分的组织学检查)。与 EUS-FNA 组(59%)相比,EUS-FNB-SC 组 95%的标本大小足以进行组织学筛查(P=0.01)。EUS-FNB-SC 组获得样本所需的中位数穿刺次数明显低于 EUS-FNA 组(2 次 vs 4 次,P=0.001)。在所有病变部位和针规中,穿刺次数的中位数均有显著差异。
与 EUS-FNA 针相比,EUS-FNB-SC 针的组织学采集效果明显更高。此外,使用 EUS-FNB-SC 时,获得组织学核心所需的穿刺次数更少。